FDA
-
-
-
-
-
-
-
KALA BIO receives $6M investment, appoints new CEO
-
-
-
-
-
-
-
KALA BIO Appoints Todd Bazemore as President, Chief Executive Officer and Director
-
-
-
-
-
-
-
KALA BIO to Present at Jefferies Global Healthcare Conference
-
-
-
-
-
-
-
KALA BIO Announces Chief Executive Officer Transition
-
-
-
-
-
-
-
Kala Pharmaceuticals (KALA) PT Lowered to $15 at H.C. Wainwright
-
-
-
-
-
-
-
KALA BIO Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
-
-
-
-
-
-
-
KALA BIO Reports Second Quarter 2023 Financial Results and Provides Corporate Update
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

